Literature DB >> 25795712

Peripheral microvascular function is altered in young individuals at risk for hypertrophic cardiomyopathy and correlates with myocardial diastolic function.

Eva Fernlund1, Todd T Schlegel2, Pyotr G Platonov3, Jonas Carlson3, Marcus Carlsson4, Petru Liuba5.   

Abstract

Hypertrophic cardiomyopathy (HCM) is a major cause of sudden cardiac death in the young. Based on previous reports of functional abnormalities in not only coronary but also peripheral vessels in adults with HCM, we aimed to assess both peripheral vascular and myocardial diastolic function in young individuals with an early stage of HCM and in individuals at risk for HCM. Children, adolescents, and young adults (mean age: 12 yr) with a family history of HCM who either had (HCM group; n = 36) or did not have (HCM-risk group; n = 30) echocardiography-documented left ventricular (LV) hypertrophy as well as healthy matched controls (n = 85) and healthy young athletes (n = 12) were included in the study. All underwent assessment with 12-lead electrocardiography, two-dimensional echocardiography, tissue Doppler imaging and laser Doppler with transdermal iontophoresis of ACh and sodium nitroprusside. LV thickness and mass were increased in HCM and athlete groups compared with control and HCM-risk groups. The mitral E-to-e' ratio, measured via tissue Doppler, was increased in HCM (P < 0.0001) and HCM-risk (P < 0.01) groups compared with control and athlete groups, as were microvascular responses to ACh (HCM group: P = 0.045 and HCM-risk group: P = 0.02). Responses to ACh correlated with the E-to-e' ratio (r = 0.5, P = 0.001). Microvascular responses to sodium nitroprusside were similar in all groups (P > 0.2). HCM-causing mutations or its familial history are associated with changes in cardiac diastolic function and peripheral microvascular function even before the onset of myocardial hypertrophy. Tissue Doppler can be used to differentiate HCM from physiological LV hypertrophy in young athletes.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  athletes' heart; diastology; early diagnosis; endothelium; myocardial hypertrophy

Mesh:

Year:  2015        PMID: 25795712     DOI: 10.1152/ajpheart.00714.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

Review 1.  Linking myofilaments to sudden cardiac death: recent advances.

Authors:  Sabine Huke
Journal:  J Physiol       Date:  2017-03-16       Impact factor: 5.182

2.  Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

Authors:  Paul J M Wijnker; Vasco Sequeira; Diederik W D Kuster; Jolanda van der Velden
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

Review 3.  Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy.

Authors:  Richard J Marszalek; R John Solaro; Beata M Wolska
Journal:  Pflugers Arch       Date:  2018-10-29       Impact factor: 3.657

Review 4.  Endothelial Dysfunction and Coronary Vasoreactivity - A Review of the History, Physiology, Diagnostic Techniques, and Clinical Relevance.

Authors:  Tharusha Gunawardena; Ioannis Merinopoulos; Upul Wickramarachchi; Vassilios Vassiliou; Simon Eccleshall
Journal:  Curr Cardiol Rev       Date:  2021

5.  Tongxinluo Reverses the Hypoxia-suppressed Claudin-9 in Cardiac Microvascular Endothelial Cells.

Authors:  Kun Liu; Xiu-Juan Wang; Yan-Ning Li; Bin Li; Jin-Sheng Qi; Jing Zhang; Yu Wang
Journal:  Chin Med J (Engl)       Date:  2016-02-20       Impact factor: 2.628

6.  Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.

Authors:  E Fernlund; T Gyllenhammar; R Jablonowski; M Carlsson; A Larsson; J Ärnlöv; P Liuba
Journal:  Pediatr Cardiol       Date:  2017-03-30       Impact factor: 1.655

7.  The Preterm Heart in Childhood: Left Ventricular Structure, Geometry, and Function Assessed by Echocardiography in 6-Year-Old Survivors of Periviable Births.

Authors:  Lilly-Ann Mohlkert; Jenny Hallberg; Olof Broberg; Annika Rydberg; Cecilia Pegelow Halvorsen; Petru Liuba; Vineta Fellman; Magnus Domellöf; Gunnar Sjöberg; Mikael Norman
Journal:  J Am Heart Assoc       Date:  2018-01-20       Impact factor: 5.501

8.  Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy.

Authors:  Kathrin Cordts; Doreen Seelig; Natalie Lund; Lucie Carrier; Rainer H Böger; Maxim Avanesov; Enver Tahir; Edzard Schwedhelm; Monica Patten
Journal:  Biomolecules       Date:  2019-07-13

9.  Hereditary Hypertrophic Cardiomyopathy in Children and Young Adults-The Value of Reevaluating and Expanding Gene Panel Analyses.

Authors:  Eva Fernlund; Antheia Kissopoulou; Henrik Green; Jan-Erik Karlsson; Rada Ellegård; Hanna Klang Årstrand; Jon Jonasson; Cecilia Gunnarsson
Journal:  Genes (Basel)       Date:  2020-12-08       Impact factor: 4.096

Review 10.  Sleep Disordered Breathing in Hypertrophic Cardiomyopathy-Current State and Future Directions.

Authors:  Shreyas Venkataraman; Shahid Karim; Aiswarya Rajendran; C Anwar A Chahal; Virend K Somers
Journal:  J Clin Med       Date:  2020-03-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.